Pharmacokinetics of methylene blue dye for lymphatic mapping in breast cancer-implications for use in pregnancy.
暂无分享,去创建一个
Brian C. Netzel | A. Degnim | J. Boughey | J. Reid | S. Pruthi | B. Brost | Caroline Haakenson | Ravinder Singh | K. Bryant
[1] A. Degnim,et al. Safety and technical success of methylene blue dye for lymphatic mapping in breast cancer. , 2008, American journal of surgery.
[2] M. Meyers,et al. Pregnancy‐Associated Breast Cancer Patients Can Safely Undergo Lymphatic Mapping , 2008, The breast journal.
[3] A. Goldhirsch,et al. Breast cancer diagnosed during pregnancy and lactation: biological features and treatment options. , 2005, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[4] H. Kuerer,et al. The Safety of Lymphatic Mapping in Pregnant Breast Cancer Patients Using Tc‐99m Sulfur Colloid , 2004, The breast journal.
[5] O. Müller,et al. Pharmacokinetic interaction of chloroquine and methylene blue combination against malaria , 2004, European Journal of Clinical Pharmacology.
[6] K. Conrad. Mechanisms of Renal Vasodilation and Hyperfiltration During Pregnancy , 2004, The Journal of the Society for Gynecologic Investigation: JSGI.
[7] A. Luini,et al. Safety of sentinel node biopsy in pregnant patients with breast cancer. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.
[8] R. Newcombe,et al. Relative value of blue dye and isotope in sentinel node localization for breast cancer in a multicentre trial , 2004 .
[9] O. Müller,et al. Methylene blue as an antimalarial agent , 2003, Redox report : communications in free radical research.
[10] Richard A Corley,et al. Evaluation of Physiologically Based Models of Pregnancy and Lactation for Their Application in Children's Health Risk Assessments , 2003, Critical reviews in toxicology.
[11] A. Stolier,et al. A comparison of methylene blue and lymphazurin in breast cancer sentinel node mapping. , 2002, American journal of surgery.
[12] A. Derossis,et al. A trend analysis of the relative value of blue dye and isotope localization in 2,000 consecutive cases of sentinel node biopsy for breast cancer. , 2001, Journal of the American College of Surgeons.
[13] R. Simmons,et al. Methylene Blue Dye as an Alternative to Isosulfan Blue Dye for Sentinel Lymph Node Localization , 2001, Annals of surgical oncology.
[14] G. Badger,et al. Plasma Volume Expansion in Early Pregnancy , 2001, Obstetrics and gynecology.
[15] B. Lauterburg,et al. Pharmacokinetics and organ distribution of intravenous and oral methylene blue , 2000, European Journal of Clinical Pharmacology.
[16] J. Cragan. Teratogen update: methylene blue. , 1999, Teratology.
[17] John F. Young,et al. Physiological "constants" for PBPK models for pregnancy. , 1997, Journal of toxicology and environmental health.
[18] R. Porat,et al. Methylene blue-induced phototoxicity: an unrecognized complication. , 1996, Pediatrics.
[19] John F. Young,et al. A physiologically based pharmacokinetic computer model for human pregnancy. , 1994, Teratology.
[20] J. Davison,et al. 8 Volume homeostasis and osmoregulation in human pregnancy , 1989 .
[21] McEnerney Jk,et al. Unfavorable neonatal outcome after intraamniotic injection of methylene blue. , 1983 .
[22] J. Crooks. Haemolytic jaundice in a neonate after intra-amniotic injection of methylene blue , 1982 .
[23] M. Gibaldi,et al. Noncompartmental Analysis Based on Statistical Moment Theory , 1982 .
[24] Robert C. Spahr,et al. Intraamniotic Injection of Methylene Blue Leading to Methemoglobinemia in One of Twins , 1980, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[25] I. Kirsch,et al. Heinz body hemolytic anemia from the use of methylene blue in neonates. , 1980, The Journal of pediatrics.
[26] J. Wagner,et al. Pharmacokinetics of highly ionized drugs. II. Methylene blue--absorption, metabolism, and excretion in man and dog after oral administration. , 1972, Journal of pharmaceutical sciences.
[27] J. Geiger. METHYLENE BLUE AS ANTIDOTE FOR CYANIDE AND CARBON MONOXIDE POISONING , 1933 .
[28] M. Brooks. METHYLENE BLUE AS ANTIDOTE FOR CYANIDE AND CARBON MONOXIDE POISONING , 1933 .
[29] P. Taylor,et al. J Soc Gynecol Investig , 2005 .
[30] T. Hurd,et al. Breast cancer in pregnancy: a literature review. , 2003, Archives of surgery.
[31] M. Mazumdar,et al. Complementarity of Blue Dye and Isotope in Sentinel Node Localization for Breast Cancer: Univariate and Multivariate Analysis of 966 Procedures , 2001, Annals of Surgical Oncology.
[32] P. Ell,et al. Targeting disseminated melanoma with radiolabelled methylene blue , 1996 .
[33] J. Davison,et al. Volume homeostasis and osmoregulation in human pregnancy. , 1989, Bailliere's clinical endocrinology and metabolism.